Morphic Therapeutic
MORF
$29.90
Share price
4.14%
Change (1 day)
-38.34%
Change (1 year)
Categories
Morphic Therapeutic (MORF) - Net assets
Net assets on the balance sheet as of March 2024 : $0.66 B
According to Morphic Therapeutic's latest financial reports the company has $0.66 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Morphic Therapeutic - Net assets on balance sheet (from 2018 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.69 B | 99.65% |
| 2022-12-31 | $0.34 B | 3.69% |
| 2021-12-31 | $0.33 B | 131.89% |
| 2020-12-31 | $0.14 B | 3.04% |
| 2019-12-31 | $0.14 B | -368.15% |
| 2018-12-31 | $-52.56 M | 76.98% |
| 2017-12-31 | $-29.7 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $1.38 B | 109.35% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $10.67 M | -98.39% | 🇺🇸 USA |